First TransNational Access Call to ERINHA’s full catalogue of services, including access to cutting edge high containment facilities was launched today!
The call is funded under the EU H2020 ERINHA-Advance project.
The following pathogens are prioritized:
Crimean Congo Hemorrhagic Fever virus
Applications must fall into one of the following scientific topics:
SECTION 1: Innovative therapeutics, vaccines or diagnosis approaches for RG4 pathogens
Development of RG4 pathogens’ standards for diagnosis
Development of innovative technologies for diagnosis
Development of innovative alternatives for antibodies production for diagnosis and therapeutics purpose
Development of innovative therapeutics tools/ immunotherapy
Development of new synthetic methods to improve immunogenicity of vaccines
Development of new approach for the design of antiviral drugs
Development of vaccines against RG4 pathogens
SECTION 2: Innovative approaches to study highly infectious viruses in animal experimentation
Optimization/ adaptation of rodent models
Development of telemetry technics/ biochemistry technics for animal experimentation
Development and optimization of alternative technologies to animal models
Development of innovative real-time imaging capacity in BSL 4 conditions
Deadline for applications: 15 December 2019
For more information please check ERINHA-Advance TNA Programme TNA section .